Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New MAb prepared at CNRS useful in RCC therapy, diagnosis

Dec. 12, 2000

Galenic formulations of antithrombotic agents for s.c. administration

Dec. 12, 2000

Preparation and use of nonsteroidal glucocorticoid receptor modulators described by Pfizer

Dec. 12, 2000

Catechols and prolines under study at Merck and Cubist as antimicrobial agents

Dec. 12, 2000

Amylin patents new PEG-modified exendins, exendin agonists

Dec. 12, 2000

Novel catechol-based COMT inhibitors designed by Orion research group

Dec. 12, 2000

Nonpeptide cathepsin D inhibitors identified at U. of California

Dec. 12, 2000

AstraZeneca presents new carboxypeptidase U inhibitors and use thereof

Dec. 11, 2000

Inhibitors of Lp-PLA2 from SB reportedly useful for atherosclerosis

Dec. 11, 2000

Nycomed Imaging identifies novel X-ray contrast agents

Dec. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...